|
⚲
|
| Keyboard |
| Tucker Sean
✚
|
|
|---|---|
| CIK # | 0001652204 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001652204] | |
| 4 | [0001652204] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tucker Sean | |
| NABI Biopharmaceuticals |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-28 | Tax withheld | 3,924 | $0.65 | 2,551 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-24 | Tax withheld | 36,418 | $0.69 | 25,128 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-18 | Tax withheld | 8,072 | $0.63 | 5,085 |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2026-03-16 | Grant | 410,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-03-16 | Grant | 200,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2026-02-02 | Tax withheld | 9,265 | $0.61 | 5,652 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-28 | Tax withheld | 3,913 | $0.42 | 1,643 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-24 | Grant | 406,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-03-24 | Grant | 610,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-18 | Tax withheld | 8,050 | $0.57 | 4,588 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-02-02 | Tax withheld | 9,242 | $0.68 | 6,285 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-03-28 | Tax withheld | 3,902 | $1.30 | 5,073 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-03-18 | Grant | 90,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2024-03-18 | Grant | 410,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-02-02 | Tax withheld | 9,220 | $1.20 | 11,064 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-12-08 | Tax withheld | 34,288 | $0.71 | 24,344 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-28 | Tax withheld | 3,683 | $0.75 | 2,762 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-17 | Grant | 54,157 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2023-03-17 | Grant | 410,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2023-03-17 | Grant | 205,000 | $0.00 | |
| showing 20 of 52 most recent transactions | |||||